Combination of nivolumab and CAN-2409 delivered during neurosurgery was generally well tolerated with no significant added toxicity compared to standard of care
Systemic immune activation was observed in peripheral
Candel Therapeutics's (NASDAQ:CADL) short percent of float has risen 15.38% since its last report. The company recently reported that it has 57 thousand shares sold short, which is 0.3% of all regular shares that are available for trading.
Gainers
Statera BioPharma (NASDAQ:STAB) shares increased by 33.1% to $0.2 during Friday's pre-market session. The company's market cap stands at $10.4 million.
Major U.S. indices closed in the red on Thursday as investors continued to digest higher Treasury yields as well as key earnings. The yield in the benchmark U.S. 10-year Treasuries topped 4.239%, a level unseen since 2008. Benzinga dives into five stocks that are seeing high interest among retail investors today, as the U.S.